Interestingly, the inhibition of TGF-β signalling allows for neurogenesis to efficiently recover following irradiation, suggesting that it may have far-reaching implications for aged individuals and for patients with cancer who are treated with cranial radiotherapy. The gene discussed is TGFB1; the disease is cancer.